PNC FINANCIAL SERVICES GROUP, INC. - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$64,000
+20.8%
13,000
+30.0%
0.00%
Q2 2021$53,000
+10.4%
10,0000.0%0.00%
Q1 2021$48,000
+60.0%
10,000
+42.9%
0.00%
Q4 2020$30,000
-51.6%
7,000
-53.3%
0.00%
Q3 2020$62,000
+63.2%
15,0000.0%0.00%
Q2 2020$38,000
+8.6%
15,000
+25.0%
0.00%
Q1 2020$35,000
-22.2%
12,0000.0%0.00%
Q4 2019$45,000
-26.2%
12,0000.0%0.00%
Q3 2019$61,000
-1.6%
12,000
+20.0%
0.00%
Q2 2019$62,000
+44.2%
10,000
+66.7%
0.00%
Q1 2019$43,000
-28.3%
6,000
+100.0%
0.00%
Q3 2018$60,000
-22.1%
3,0000.0%0.00%
Q2 2018$77,000
+6.9%
3,0000.0%0.00%
Q1 2018$72,000
-29.4%
3,0000.0%0.00%
Q4 2017$102,000
+59.4%
3,0000.0%0.00%
Q3 2017$64,000
+20.8%
3,000
-0.5%
0.00%
Q2 2017$53,0000.0%3,015
+0.5%
0.00%
Q1 2017$53,000
+3.9%
3,0000.0%0.00%
Q4 2016$51,000
+4.1%
3,0000.0%0.00%
Q3 2016$49,000
+6.5%
3,000
-2.0%
0.00%
Q2 2016$46,000
+4.5%
3,062
-0.1%
0.00%
Q1 2016$44,000
-49.4%
3,064
+0.1%
0.00%
Q4 2015$87,000
+8600.0%
3,062
+4838.7%
0.00%
Q3 2015$1,000
-50.0%
62
+3.3%
0.00%
Q2 2015$2,000
+100.0%
60
+76.5%
0.00%
Q1 2015$1,000
-50.0%
34
-66.0%
0.00%
Q4 2014$2,0001000.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders